Piotrowski, A.F.; Shih, K.; Giglio, P.; Colman, H.; Wen, P.Y.; Campian, J.L.; Butowski, N.; Cloughesy, T.; Zhu, Z.; Gisin, V.;
et al. Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma. Curr. Oncol. 2025, 32, 541.
https://doi.org/10.3390/curroncol32100541
AMA Style
Piotrowski AF, Shih K, Giglio P, Colman H, Wen PY, Campian JL, Butowski N, Cloughesy T, Zhu Z, Gisin V,
et al. Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma. Current Oncology. 2025; 32(10):541.
https://doi.org/10.3390/curroncol32100541
Chicago/Turabian Style
Piotrowski, Anna F., Kent Shih, Pierre Giglio, Howard Colman, Patrick Y. Wen, Jian Li Campian, Nicholas Butowski, Timothy Cloughesy, Zhaoyin Zhu, Vitaliy Gisin,
and et al. 2025. "Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma" Current Oncology 32, no. 10: 541.
https://doi.org/10.3390/curroncol32100541
APA Style
Piotrowski, A. F., Shih, K., Giglio, P., Colman, H., Wen, P. Y., Campian, J. L., Butowski, N., Cloughesy, T., Zhu, Z., Gisin, V., & Badruddoja, M.
(2025). Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma. Current Oncology, 32(10), 541.
https://doi.org/10.3390/curroncol32100541
